TruTouch Technologies Signs Clinical Trial Agreement With Lovelace Respiratory Research Institute & Lovelace Scientific Resources for Clinical Trial of Next-Generation Alcohol Intoxication Screening Device
10/16/2012 10:11:19 AM
FRAMINGHAM, Mass. & ALBUQUERQUE, N.M.--(BUSINESS WIRE)--TruTouch Technologies, a pioneer in non-invasive alcohol intoxication and biometric measurement systems, today announced that it has signed a Clinical Trial agreement for the next generation of the Company's alcohol screening device with Lovelace Respiratory Research Institute (LRRI) and Lovelace Scientific Resources (LSR), an Albuquerque, N.M.-based, FDA-approved contract research organization.
comments powered by